AEterna Zentaris
(NASDAQ:AEZS)
$2.04
0.06[3.03%]
At close: Apr 5
$2.04
0[0.00%]
After Hours: 7:11PM EDT
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diag...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
AEZS

FAQ

Q

How do I buy AEterna Zentaris (AEZS) stock?

A

You can purchase shares of AEterna Zentaris (NASDAQ: AEZS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are AEterna Zentaris's (AEZS) competitors?

A

There are no as such competitors for AEterna Zentaris.

Q

What is the target price for AEterna Zentaris (AEZS) stock?

A

The latest price target for AEterna Zentaris (NASDAQ: AEZS) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 15.00 expecting AEZS to rise to within 12 months (a possible 635.29% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for AEterna Zentaris (AEZS)?

A

The stock price for AEterna Zentaris (NASDAQ: AEZS) is $2.04 last updated April 5, 2024 at 7:11 PM EDT.

Q

Does AEterna Zentaris (AEZS) pay a dividend?

A

There are no upcoming dividends for AEterna Zentaris.

Q

When is AEterna Zentaris (NASDAQ:AEZS) reporting earnings?

A

AEterna Zentaris’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is AEterna Zentaris (AEZS) going to split?

A

There is no upcoming split for AEterna Zentaris.

Q

What sector and industry does AEterna Zentaris (AEZS) operate in?

A

AEterna Zentaris is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.